Word

TRANSCARDIA

Status

Dead

Status Code

606

Status Date

Monday, March 18, 2024

Serial Number

97314595

Mark Type

4000

Filing Date

Wednesday, March 16, 2022

Published for Opposition

Tuesday, June 20, 2023

Abandoned Date

Monday, March 18, 2024

Trademark Owner History

Transcardia, LLC - Owner At Publication

Classifications

45 Regulatory compliance consulting, namely consulting in the field of regulatory affairs including for pharmaceuticals, therapies, and medical devices in the preclinical, clinical and commercial stage

44 Providing medical information, consultancy, and advisory services to medical professionals in the field of gene modification technology, organ transplants, xenotransplantation, regenerative medicine, advanced therapies, advanced therapeutic medicinal products, biologics, pharmaceuticals and medical devices; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical evaluation services for patients of gene modification, organ transplants, xenotransplantation, regenerative medicine, and advanced therapies for purposes of guiding treatment and assessing effectiveness

42 Scientific and technological consulting services, namely, providing medical and scientific research information in the field of gene modification technology, organ transplants, xenotransplantation, regenerative medicine, advanced therapies, advanced therapeutic medicinal products, biologics, pharmaceuticals, and medical devices; Scientific and technological research, namely, providing information in the field of pharmaceutical preclinical and clinical research and development; quality management services, namely quality evaluation and analysis, quality assurance, and quality control in the field of gene modification technology, organ transplants, xenotransplantation, regenerative medicine, advanced therapies, advanced therapeutic medicinal products, biologics, pharmaceuticals, and medical device manufacturing; scientific research and development for medical purposes; compiling data for research purposes in the field of medical science and medical consultancy; design and testing for new product development relating to the aforementioned services

Trademark Events

Mar 18, 2024

Abandonment Notice E-Mailed - No Use Statement Filed

Mar 18, 2024

Abandonment - No Use Statement Filed

Aug 15, 2023

Noa E-Mailed - Sou Required From Applicant

Jun 20, 2023

Official Gazette Publication Confirmation E-Mailed

Jun 20, 2023

Published For Opposition

May 31, 2023

Notification Of Notice Of Publication E-Mailed

May 15, 2023

Approved For Pub - Principal Register

Apr 5, 2023

Teas/Email Correspondence Entered

Apr 4, 2023

Correspondence Received In Law Office

Apr 4, 2023

Teas Response To Office Action Received

Jan 13, 2023

Notification Of Non-Final Action E-Mailed

Jan 13, 2023

Non-Final Action E-Mailed

Jan 13, 2023

Non-Final Action Written

Dec 28, 2022

Assigned To Examiner

Mar 21, 2022

New Application Office Supplied Data Entered

Mar 19, 2022

New Application Entered